Zai Lab Ltd
ZLAB
DELAYED 1 MONTH
16 insider filings · Latest: May 26, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | May 19 8:18 PM | Ying DuDirector, Chairperson & CEO | Sale | 50,000 | $19.00 | $949.8K | 1,122,626(D) | View → |
| May 15, 2026 | May 19 8:18 PM | Ying DuDirector, Chairperson & CEO | Sale | 50,000 | $20.74 | $1.0M | 1,122,626(D) | View → |
| May 14, 2026 | May 15 8:46 PM | Frazor Titus Edmondson IIIChief Legal Officer | Sale | 3,517 | $20.19 | $71.0K | 19,849(D) | View → |
| May 14, 2026 | May 15 8:45 PM | Ying DuDirector, Chairperson & CEO | Sale | 50,000 | $20.09 | $1.0M | 1,122,626(D) | View → |
| May 13, 2026 | May 15 8:45 PM | Ying DuDirector, Chairperson & CEO | Sale | 50,000 | $19.97 | $998.5K | 1,122,626(D) | View → |
| Mar 13, 2026 | Mar 16 8:09 PM | Joshua L SmileyPresident and Chief Operating Officer | Sale | 1,966 | $18.63 | $36.6K | 91,026(D) | View → |
| Mar 13, 2026 | Mar 16 8:08 PM | Frazor Titus Edmondson IIIChief Legal Officer | Sale | 1,281 | $18.63 | $23.9K | 6,494(D) | View → |
| Mar 13, 2026 | Mar 16 8:08 PM | Yajing ChenChief Financial Officer | Sale | 1,703 | $18.63 | $31.7K | 19,999(D) | View → |
| Mar 13, 2026 | Mar 16 8:07 PM | Rafael AmadoPresident, Head of Global Oncology Research and Development | Sale | 2,957 | $18.63 | $55.1K | 44,757(D) | View → |
| Mar 11, 2026 | Mar 12 8:12 PM | Ying DuDirector, Chairperson & CEO | Sale | 1,067 | $19.08 | $20.4K | 1,109,905(D) | View → |
| Mar 9, 2026 | Mar 10 8:08 PM | Ying DuDirector, Chairperson & CEO | Sale | 50,000 | $19.03 | $951.5K | 964,161(D) | View → |
| Mar 6, 2026 | Mar 10 8:08 PM | Ying DuDirector, Chairperson & CEO | Sale | 50,000 | $19.42 | $970.9K | 964,161(D) | View → |
| Mar 5, 2026 | Mar 6 9:26 PM | Frazor Titus Edmondson IIIChief Legal Officer | Sale | 15,569 | $19.06 | $296.7K | 3,517(D) | View → |
| Mar 5, 2026 | Mar 6 9:25 PM | Ying DuDirector, Chairperson & CEO | Sale | 50,000 | $19.22 | $961.1K | 964,161(D) | View → |
| Mar 4, 2026 | Mar 6 9:25 PM | Ying DuDirector, Chairperson & CEO | Sale | 50,000 | $19.16 | $958.2K | 964,161(D) | View → |
| Mar 3, 2026 | Mar 5 9:07 PM | Rafael AmadoPresident, Head of Global Oncology Research and Development | Sale | 10,000 | $17.38 | $173.8K | 42,391(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 11, 2026 | Jun 8 8:29 PM | Yizhe WangOperating Partner | Grant/Award | 196,107 | $20.32 | 59,288(D) | View → |
| May 19, 2026 | May 21 8:19 PM | Ying DuDirector, Chairperson & CEO | Option Exercise | 261,092 | $1.74 | 0(D) | View → |
| May 18, 2026 | May 19 8:18 PM | Ying DuDirector, Chairperson & CEO | Option Exercise | 50,000 | $1.74 | 261,092(D) | View → |
| May 15, 2026 | May 19 8:18 PM | Ying DuDirector, Chairperson & CEO | Option Exercise | 50,000 | $1.74 | 311,092(D) | View → |
| May 14, 2026 | May 15 8:45 PM | Ying DuDirector, Chairperson & CEO | Option Exercise | 50,000 | $1.74 | 361,092(D) | View → |
| May 13, 2026 | May 15 8:45 PM | Ying DuDirector, Chairperson & CEO | Option Exercise | 50,000 | $1.74 | 411,092(D) | View → |
| Mar 12, 2026 | Mar 16 8:09 PM | Joshua L SmileyPresident and Chief Operating Officer | Option Exercise | 6,388 | — | 19,165(D) | View → |
| Mar 4, 2026 | Mar 16 8:09 PM | Joshua L SmileyPresident and Chief Operating Officer | Grant/Award | 137,733 | $19.27 | 33,783(D) | View → |
| Mar 12, 2026 | Mar 16 8:08 PM | Frazor Titus Edmondson IIIChief Legal Officer | Option Exercise | 4,258 | — | 12,777(D) | View → |
| Mar 4, 2026 | Mar 16 8:08 PM | Frazor Titus Edmondson IIIChief Legal Officer | Grant/Award | 110,187 | $19.27 | 27,027(D) | View → |
| Mar 12, 2026 | Mar 16 8:08 PM | Yajing ChenChief Financial Officer | Option Exercise | 4,258 | — | 12,777(D) | View → |
| Mar 4, 2026 | Mar 16 8:08 PM | Yajing ChenChief Financial Officer | Grant/Award | 110,187 | $19.27 | 27,027(D) | View → |
| Mar 12, 2026 | Mar 16 8:07 PM | Rafael AmadoPresident, Head of Global Oncology Research and Development | Option Exercise | 5,323 | — | 15,971(D) | View → |
| Mar 4, 2026 | Mar 16 8:07 PM | Rafael AmadoPresident, Head of Global Oncology Research and Development | Grant/Award | 137,733 | $19.27 | 33,783(D) | View → |
| Mar 11, 2026 | Mar 16 8:06 PM | Ying DuDirector, Chairperson & CEO | Grant/Award | 385,849 | $19.34 | 32,419(D) | View → |
| Mar 10, 2026 | Mar 12 8:12 PM | Ying DuDirector, Chairperson & CEO | Option Exercise | 263,747 | $1.74 | 7,965(D) | View → |
| Mar 9, 2026 | Mar 10 8:08 PM | Ying DuDirector, Chairperson & CEO | Option Exercise | 50,000 | $1.74 | 722,184(D) | View → |
| Mar 6, 2026 | Mar 10 8:08 PM | Ying DuDirector, Chairperson & CEO | Option Exercise | 50,000 | $1.74 | 772,184(D) | View → |
| Mar 5, 2026 | Mar 6 9:25 PM | Ying DuDirector, Chairperson & CEO | Option Exercise | 50,000 | $1.74 | 822,184(D) | View → |
| Mar 4, 2026 | Mar 6 9:25 PM | Ying DuDirector, Chairperson & CEO | Option Exercise | 50,000 | $1.74 | 872,184(D) | View → |